Thank you to the chair and members for inviting me back to the committee. It is my pleasure to be here. I hope I can be of assistance.
I am joined today by the deputy procurement ombudsman, David Rabinovitch, who is also participating via Zoom from his residence.
I would like to begin my remarks by thanking Canada's health care workers who are on the front lines of this pandemic risking their own health and well-being to lead us through these difficult times.
I would also like to thank all the people who work behind the scenes and provide essential services to ensure that Canadians can eat well, and stay in a safe place.
I also thank the public servants at all levels of government, across Canada, who work tirelessly to ensure access to screening tests, medical equipment, personal protective equipment, financial assistance and other necessary supports.
Thank you to the IT, translation and administrative professionals who make it possible for us to work remotely, including enabling us to do the important work the committee is doing today.
Now, I would like to explain to you my role and mandate. I would like to explain my role within federal procurement as some of you may not have been here on the committee when I was last here, two years ago.
The Office of the Procurement Ombudsman opened in 2008 with a focus on providing small and medium-sized businesses an avenue of recourse for procurement and contracting issues. My office operates at arm's length from other federal organizations, including Public Services and Procurement Canada.
While I report the Minister of Public Services and Procurement, the minister has no direct involvement in my office's daily activities or the content of my reports.
Specifically my legislative mandate is, first, to review complaints regarding the awards of certain contracts for goods below $26,400 and services below $105,700; second, to review complaints regarding the administration of certain contracts regardless of their dollar value; third, to review the department's practices for acquiring goods and services to assess their fairness, openness and transparency, and to make recommendations for improvement; and fourth, to provide alternative dispute resolution, like mediation services when requested and agreed to by the parties to a federal contract.
As you can see, the mandate is quite specific. This is because the Canadian International Trade Tribunal has jurisdiction to review complaints about the award of contracts above these thresholds of $26,400 for goods and $105,700 for services.
Now I will talk a little bit about the Government of Canada and its COVID-19 response.
My office specifically has not been inundated by COVID-19 procurement and contracting related complaints. My office's key services, which are reviewing complaints about the award of lower dollar value contracts and providing contract mediation services, are more likely to be needed in subsequent phases of the recovery. When the office of small and medium enterprises asked for our help in responding to the over 26,000 calls and emails from suppliers looking to sell COVID-19 related products to the federal government, we immediately sent them several employees to assist in contacting these companies to move the process forward.
We have heard from some suppliers regarding COVID-19 issues, and I will briefly describe some of these interactions.
One supplier contacted us with complaints about the procurement processes for chartered evacuation flights. However, as the dollar amounts of those contracts were well above the threshold of my mandate, we let the supplier know that the CITT has jurisdiction to investigate these types of complaints.
We've also received inquiries from suppliers about selling hospital beds to assist with COVID-19 outbreaks; sending bulk PPE supplies to the government; waiving normal procurement requirements; selling disinfecting materials; selling medical masks; donating hand sanitizers, and how to sell the same in the future to the government; and how to purchase specific types of ventilators.
For each of these inquiries, just as with non-COVID-19 inquiries, we explain our mandate to the supplier in case they need our investigation services or our remediation services. We provide them with an answer directly or point them to a federal organization that can. For example, the companies that contacted us wanted to know who to call for masks and hand sanitizers. We directed them to the office of small and medium enterprises, which you will hear from next and which is specifically designed for this purpose.
We have not received any formal requests for mediation services in regards to either COVID-19 related contracts or other contracts that may have been impacted by the COVID-19 pandemic. As mentioned earlier, it is anticipated, however, that formal complaints and mediation request may come further down the road. For now, it's too soon, as COVID-19 related contracts are just being put into place.
Moving forward, to be proactive, my office is studying the issue of emergency contracting, both in terms of how the contracts are put in place as well as what transpires when contractual obligations cannot be met due to unexpected emergency conditions known as force majeure.
We intend to share our research with both federal departments and suppliers, to help all parties to federal contracts know how to proceed when crises such as COVID-19 happen. We also want to hear from all Canadian suppliers, including small and medium-sized business owners and diverse business owners, to learn about their experiences during this crisis so we can share the information broadly with contracting organizations.
As time passes, we anticipate receiving complaints from businesses that hoped to but did not obtain federal contracts during this crisis and mediation requests regarding existing contracts that were not completed due to the crisis. As always, we will be there to review these complaints and to provide our mediation services so that businesses and departments can get back to business. My office has a successful track record in mediating contract disputes, and I urge all of you and anyone listening to contact us for help in this area. I would welcome the opportunity to come back to this committee in the future to report back on our COVID-related work and findings.
In closing, I would like to thank committee members again for inviting me, and I would be pleased to answer your questions.